Aggressive Mediastinal Lymphomas
Seminars in Diagnostic Pathology, ISSN: 0740-2570, Vol: 41, Issue: 3, Page: 125-139
2024
- 5Citations
- 11Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations5
- Citation Indexes5
- CrossRef4
- Captures11
- Readers11
- 11
- Mentions1
- News Mentions1
- 1
Most Recent News
Studies from University of Texas MD Anderson Cancer Center in the Area of Lymphoma Reported (Aggressive Mediastinal Lymphomas)
2024 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Hematology Daily -- Investigators publish new report on Oncology - Lymphoma. According
Review Description
The mediastinum contains essentially all major intrathoracic organs except for the lungs. A variety of both benign and malignant tumors can involve the mediastinum, of which lymphoma is the most common malignancy. Compared to secondary mediastinal involvement by systemic lymphomas, primary mediastinal lymphomas are less common with several specific entities that are mainly confined to mediastinal lymph nodes, and/or thymus. This review will summarize the clinical, histologic, immunophenotypic and molecular genetic features of the most common and most aggressive primary mediastinal lymphomas as well as provide suggested immunohistochemistry panels and differential diagnoses.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0740257021000496; http://dx.doi.org/10.1053/j.semdp.2021.06.010; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85108534004&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/34175178; https://linkinghub.elsevier.com/retrieve/pii/S0740257021000496; https://dx.doi.org/10.1053/j.semdp.2021.06.010
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know